Skip to main content
icon for Flu Hospitalization Rate Week 17, 2026?

Flu Hospitalization Rate Week 17, 2026?

icon for Flu Hospitalization Rate Week 17, 2026?

Flu Hospitalization Rate Week 17, 2026?

Ended: Mai 8

Juni 19

Ended: Mai 8

Juni 19

85–90 100.0%

<80 <1%

80–85 <1%

90–95 <1%

Polymarket

$13,590 Vol.

85–90 100.0%

<80 <1%

80–85 <1%

90–95 <1%

Polymarket

$13,590 Vol.

<80

$1,247 Vol.

No

80–85

$1,643 Vol.

No

85–90

$5,033 Vol.

Yes

90–95

$2,964 Vol.

No

95–100

$1,433 Vol.

No

100+

$1,271 Vol.

No

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC's FluView surveillance report for Week 17 (ending May 2, 2026), released today, confirms a cumulative influenza hospitalization rate of 86.0 per 100,000 population through FluSurv-NET sites covering 9% of the U.S. population—a third-highest level since the 2010-11 season amid an intense year with an estimated 32 million illnesses and 380,000 hospitalizations dominated by A(H3N2). This uptick from 85.7 per 100,000 in Week 16 aligns trader consensus at 100% for the 85–90 bin, reflecting skin-in-the-game agreement with authoritative data as weekly rates plummet to 0.2 per 100,000 amid low seasonal activity. Realistic challenges include rare CDC revisions from reporting lags, though final FluSurv-NET figures carry high reliability.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$13,590
Enddatum
8. Mai 2026
Markt eröffnet
Apr 30, 2026, 2:36 PM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Vorgeschlagenes Ergebnis: No

Kein Einspruch

Endgültiges Ergebnis: No

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC's FluView surveillance report for Week 17 (ending May 2, 2026), released today, confirms a cumulative influenza hospitalization rate of 86.0 per 100,000 population through FluSurv-NET sites covering 9% of the U.S. population—a third-highest level since the 2010-11 season amid an intense year with an estimated 32 million illnesses and 380,000 hospitalizations dominated by A(H3N2). This uptick from 85.7 per 100,000 in Week 16 aligns trader consensus at 100% for the 85–90 bin, reflecting skin-in-the-game agreement with authoritative data as weekly rates plummet to 0.2 per 100,000 amid low seasonal activity. Realistic challenges include rare CDC revisions from reporting lags, though final FluSurv-NET figures carry high reliability.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$13,590
Enddatum
8. Mai 2026
Markt eröffnet
Apr 30, 2026, 2:36 PM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Vorgeschlagenes Ergebnis: No

Kein Einspruch

Endgültiges Ergebnis: No

Vorsicht bei externen Links.

Häufig gestellte Fragen

„Flu Hospitalization Rate Week 17, 2026?" ist ein Prognosemarkt auf Polymarket mit 6 möglichen Ergebnissen, bei dem Händler Anteile auf Basis ihrer Einschätzung kaufen und verkaufen. Das aktuell führende Ergebnis ist „85–90" mit 100%, gefolgt von „<80" mit 0%. Die Preise spiegeln Echtzeit-Wahrscheinlichkeiten der Community wider. Ein Anteilspreis von 100¢ bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 100% zuweist. Diese Quoten ändern sich laufend, wenn Händler auf neue Entwicklungen reagieren. Anteile am richtigen Ergebnis können bei Marktauflösung für jeweils $1 eingelöst werden.

Stand heute hat „Flu Hospitalization Rate Week 17, 2026?" ein Gesamthandelsvolumen von $13.6K generiert, seit der Markt am Apr 30, 2026 gestartet wurde. Dieses Aktivitätsniveau spiegelt starkes Engagement der Polymarket-Community wider und stellt sicher, dass die aktuellen Quoten von einem breiten Pool an Marktteilnehmern geprägt werden. Sie können Live-Preisbewegungen verfolgen und direkt auf dieser Seite auf jedes Ergebnis handeln.

Um auf „Flu Hospitalization Rate Week 17, 2026?" zu handeln, durchsuchen Sie die 6 verfügbaren Ergebnisse auf dieser Seite. Jedes Ergebnis zeigt einen aktuellen Preis, der die implizierte Wahrscheinlichkeit des Marktes darstellt. Um eine Position einzunehmen, wählen Sie das Ergebnis, das Sie für am wahrscheinlichsten halten, wählen Sie „Ja" um dafür oder „Nein" um dagegen zu handeln, geben Sie Ihren Betrag ein und klicken Sie auf „Handeln". Liegt Ihr gewähltes Ergebnis bei Marktauflösung richtig, zahlen Ihre „Ja"-Anteile jeweils $1 aus. Liegt es falsch, zahlen sie $0. Sie können Ihre Anteile auch jederzeit vor der Auflösung verkaufen.

Der aktuelle Favorit für „Flu Hospitalization Rate Week 17, 2026?" ist „85–90" mit 100%, was bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 100% zuweist. Das nächstliegende Ergebnis ist „<80" mit 0%. Diese Quoten werden in Echtzeit aktualisiert, wenn Händler Anteile kaufen und verkaufen. Schauen Sie regelmäßig vorbei oder speichern Sie diese Seite als Lesezeichen.

Die Auflösungsregeln für „Flu Hospitalization Rate Week 17, 2026?" definieren genau, was passieren muss, damit jedes Ergebnis als Gewinner erklärt wird – einschließlich der offiziellen Datenquellen zur Bestimmung des Ergebnisses. Sie können die vollständigen Auflösungskriterien im Abschnitt „Regeln" auf dieser Seite über den Kommentaren einsehen. Wir empfehlen, die Regeln vor dem Handeln sorgfältig zu lesen, da sie die genauen Bedingungen, Sonderfälle und Quellen festlegen.